In November, the Food and Drug Administration (FDA) approved r-SNM, the first rechargeable sacral nerve stimulator cleared for full-body MRI scans, and sales results from the initial launch were ...
Zacks Investment Research on MSN
Medtronic Receives FDA Nod for Altaviva Device: Stock to Gain?
Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...
The US Food and Drug Administration (FDA) has approved Medtronic’s Altaviva device, intended for the treatment of urge urinary incontinence. This implantable tibial neuromodulation (ITNM) device ...
Bladder leakage is a problem for 60-percent of women. These kinds of incontinence issues can be a big problem, and significantly impact quality of life. Sarah Avrech is a mom of three. She started ...
Kathy Boehm shows where the charger is placed to recharge her implant. The charger can be in a belt or tucked inside her pants. Dr. Tarek Garas Dr. Lindsey Hahn Locating the nearest bathroom when she ...
In September 2025, Medtronic announced it had received FDA approval and launched the Altaviva device, a minimally invasive ...
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...
It's a problem nobody wants to talk about, suffering in silence and embarrassment. Of the 25 million Americans living with incontinence, 80% are women. But a pacemaker for the bladder may be the ...
CINCINNATI (WKRC) - A groundbreaking device that functions like a pacemaker for the bladder was offering hope to those suffering from overactive bladder, a condition marked by urinary urgency, ...
Medtronic is upping the ante in a patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic’s InterStim device, an implanted ...
The advertiser paid a fee to promote this sponsored article and may have influenced or authored the content. The views expressed in this article are those of the advertiser and do not necessarily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results